To make better decisions in a rapidly changing economy, executives require access to expert business and market intelligence. To meet this need, Insight Pharma Reports introduces its Corporate Global License and Company Site License programs. These two programs are designed to provide our customers with greater access to a large portfolio of business assessment reports.
Corporate Global License Program
- Provides worldwide access to all employees for each report purchased.
- Maximized dissemination of information within a searchable PDF on your corporate Intranet.
- Control costs and maximize budgets through coordinated purchases and reduced duplicates.
- Ideal program for multinational organization.
- Up to a 50% reduction in price when purchasing multiple global licenses.
Company Site License Program
- Full site access to all employees for each report purchased.
- Maximized dissemination of information with a searchable PDF at an individual location.
- Ideal program for small to mid-sized organizations.
- Up to a 50% reduction in price when purchasing multiple site licenses.
Insight Pharma Reports has developed and maintained a very impressive and loyal client base, including senior level executives, global competitive intelligence executives, librarians, information specialists, and research scientists.
Our reports focus exclusively on biopharmaceutical R&D – therapeutic pipelines & disease markets, enabling technology & diagnostics, clinical development, and industry dynamics & strategic issues.
For a complimentary consultation on how we might be able to help you with your information needs, while helping you stay within your budget, please contact David Cunningham at 781-972-5472 or cunningham@healthtech.com; or fill out the on-line form.